What is the most likely diagnosis for a 10-year-old patient presenting with polyuria (excessive urine production), polydipsia (excessive thirst), an elevated Hemoglobin A1c (HbA1c) level, and a low C-peptide level?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Type 1 Diabetes Mellitus

The most likely diagnosis is Type 1 diabetes mellitus (Option A), as the profoundly low C-peptide level of 0.09 indicates near-complete loss of endogenous insulin production from autoimmune beta-cell destruction, which is the pathophysiologic hallmark that distinguishes Type 1 diabetes from all other forms of diabetes. 1

Diagnostic Reasoning

C-Peptide as the Key Discriminator

  • C-peptide is secreted in equimolar amounts with insulin and directly reflects pancreatic beta-cell function; a level this low essentially excludes Type 2 diabetes and MODY, both of which retain significant insulin production capacity. 1
  • The American Diabetes Association specifically recommends using C-peptide levels to discriminate between Type 1 and Type 2 diabetes, as low C-peptide indicates the near-complete loss of endogenous insulin production characteristic of Type 1 diabetes. 1

Clinical Presentation Supports Type 1 Diabetes

  • Polyuria and polydipsia are classic presenting symptoms of Type 1 diabetes in children, reflecting osmotic diuresis from hyperglycemia. 1
  • The patient's age of 10 years falls within the peak incidence range for Type 1 diabetes onset in childhood. 1
  • The HbA1c of 6.8% indicates chronic hyperglycemia over the preceding 2-3 months, consistent with progressive beta-cell destruction. 1

Why Other Diagnoses Are Excluded

Type 2 Diabetes (Option B) - Ruled Out

  • Type 2 diabetes would show preserved or even elevated C-peptide levels due to insulin resistance with maintained beta-cell function, which is completely inconsistent with the profoundly low C-peptide of 0.09 seen in this patient. 1
  • Type 2 diabetes in children typically presents with obesity, acanthosis nigricans, and family history of Type 2 diabetes—none of which override the definitive C-peptide evidence. 1

MODY (Option C) - Ruled Out

  • MODY typically presents with mild hyperglycemia and preserved C-peptide levels, as these are genetic defects in beta-cell function rather than autoimmune destruction; the severely depleted C-peptide is pathophysiologically inconsistent with MODY. 1
  • MODY patients maintain significant insulin secretory capacity despite their genetic beta-cell dysfunction. 1

Stress-Induced Hyperglycemia (Option D) - Ruled Out

  • Stress-induced hyperglycemia is transient and would not produce an elevated HbA1c of 6.8%, which reflects months of sustained hyperglycemia. 1
  • C-peptide would be normal or elevated in stress states due to counter-regulatory hormone responses, not profoundly suppressed to 0.09. 1

Critical Clinical Pitfalls to Avoid

  • Never delay insulin initiation in a child with Type 1 diabetes presenting with polyuria and polydipsia, as these patients can rapidly progress to diabetic ketoacidosis. 2
  • Do not be misled by a "borderline" HbA1c of 6.8%—in the context of profoundly low C-peptide and classic symptoms, this confirms the diagnosis regardless of the absolute HbA1c value. 1
  • The C-peptide level is the definitive discriminator in this clinical scenario and overrides all other considerations when this profoundly suppressed. 1

References

Guideline

Type 1 Diabetes Mellitus Diagnosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Initial Treatment of Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.